Cargando…
Endogenous inhibitory mechanisms in asthma
Endogenous inhibitory mechanisms promote resolution of inflammation, enhance tissue repair and integrity, and promote homeostasis in the lung. These mechanisms include steroid hormones, regulatory T cells, IL-10, prostaglandin E(2), prostaglandin I(2), lipoxins, resolvins, protectins, maresins, gluc...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509980/ https://www.ncbi.nlm.nih.gov/pubmed/37781649 http://dx.doi.org/10.1016/j.jacig.2023.100135 |
| _version_ | 1785107868975890432 |
|---|---|
| author | Chiarella, Sergio E. Barnes, Peter J. |
| author_facet | Chiarella, Sergio E. Barnes, Peter J. |
| author_sort | Chiarella, Sergio E. |
| collection | PubMed |
| description | Endogenous inhibitory mechanisms promote resolution of inflammation, enhance tissue repair and integrity, and promote homeostasis in the lung. These mechanisms include steroid hormones, regulatory T cells, IL-10, prostaglandin E(2), prostaglandin I(2), lipoxins, resolvins, protectins, maresins, glucagon-like peptide-1 receptor, adrenomedullin, nitric oxide, and carbon monoxide. Here we review the most recent literature regarding these endogenous inhibitory mechanisms in asthma, which remain a promising target for the prevention and treatment of asthma. |
| format | Online Article Text |
| id | pubmed-10509980 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105099802023-09-29 Endogenous inhibitory mechanisms in asthma Chiarella, Sergio E. Barnes, Peter J. J Allergy Clin Immunol Glob Review Article Endogenous inhibitory mechanisms promote resolution of inflammation, enhance tissue repair and integrity, and promote homeostasis in the lung. These mechanisms include steroid hormones, regulatory T cells, IL-10, prostaglandin E(2), prostaglandin I(2), lipoxins, resolvins, protectins, maresins, glucagon-like peptide-1 receptor, adrenomedullin, nitric oxide, and carbon monoxide. Here we review the most recent literature regarding these endogenous inhibitory mechanisms in asthma, which remain a promising target for the prevention and treatment of asthma. Elsevier 2023-07-05 /pmc/articles/PMC10509980/ /pubmed/37781649 http://dx.doi.org/10.1016/j.jacig.2023.100135 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Review Article Chiarella, Sergio E. Barnes, Peter J. Endogenous inhibitory mechanisms in asthma |
| title | Endogenous inhibitory mechanisms in asthma |
| title_full | Endogenous inhibitory mechanisms in asthma |
| title_fullStr | Endogenous inhibitory mechanisms in asthma |
| title_full_unstemmed | Endogenous inhibitory mechanisms in asthma |
| title_short | Endogenous inhibitory mechanisms in asthma |
| title_sort | endogenous inhibitory mechanisms in asthma |
| topic | Review Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509980/ https://www.ncbi.nlm.nih.gov/pubmed/37781649 http://dx.doi.org/10.1016/j.jacig.2023.100135 |
| work_keys_str_mv | AT chiarellasergioe endogenousinhibitorymechanismsinasthma AT barnespeterj endogenousinhibitorymechanismsinasthma |